StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) income statement

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$19.19+0.67 (+3.62%)

Close on Nov 20, 2026Market cap $1.18BP/E –Yield –

See a number that looks wrong?